Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.31% | 165.69 | 0.7% | $1175.46m | |
| PFE | Pfizer Inc. | 1.42% | 37.07 | 0.9% | $1154.26m | |
| LLY | Eli Lilly & Co. | 2.41% | 211.11 | 1.1% | $956.27m | |
| ABBV | AbbVie, Inc. | -0.22% | 110.62 | 1.9% | $730.56m | |
| BMY | Bristol-Myers Squibb Co. | 0.19% | 64.68 | 1.0% | $680.46m | |
| MRK | Merck & Co., Inc. | 0.06% | 81.03 | 0.7% | $678.46m | |
| AZN | AstraZeneca Plc | 1.00% | 53.78 | 1.2% | $676.41m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 1.68% | 68.84 | 0.0% | $233.85m | |
| VTRS | Viatris, Inc. | -1.49% | 17.17 | 0.0% | $190.67m | |
| GRTS | Gritstone Oncology, Inc. | -10.92% | 24.15 | 0.0% | $188.00m | |
| NVS | Novartis AG | 1.26% | 98.12 | 0.2% | $176.16m | |
| RPRX | Royalty Pharma Plc | 0.80% | 51.57 | 0.2% | $175.66m | |
| GSK | GlaxoSmithKline Plc | 1.36% | 38.88 | 0.2% | $156.51m | |
| SNY | Sanofi | -0.42% | 49.48 | 0.2% | $134.41m | |
| RGEN | Repligen Corp. | -1.46% | 216.12 | 6.9% | $77.25m |
Company Profile
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.